The estimated Net Worth of Ronald Richard is at least $3.73 Millón dollars as of 25 November 2022. Mr. Richard owns over 1,912 units of Emergent Biosolutions Inc stock worth over $150,166 and over the last 18 years he sold EBS stock worth over $3,190,518. In addition, he makes $390,500 as Lead Independent Director at Emergent Biosolutions Inc.
Ronald has made over 20 trades of the Emergent Biosolutions Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 1,912 units of EBS stock worth $22,829 on 25 November 2022.
The largest trade he's ever made was exercising 23,681 units of Emergent Biosolutions Inc stock on 12 December 2017 worth over $251,966. On average, Ronald trades about 4,095 units every 69 days since 2006. As of 25 November 2022 he still owns at least 19,837 units of Emergent Biosolutions Inc stock.
You can see the complete history of Mr. Richard stock trades at the bottom of the page.
Ronald B. Richard is Lead Independent Director of the Company. Mr. Richard has served as the president and chief executive officer of the Cleveland Foundation, the nation's oldest community foundation, since June 2003. From August 2002 to February 2003, Mr. Richard served as president of Stem Cell Preservation, Inc., a start-up medical research company. After leaving Stem Cell Preservation and prior to joining our board of directors, Mr. Richard served as a strategic business advisor for IGEN International, Inc., a biotechnology company. Mr. Richard served as chief operating officer of In-Q-Tel, a venture capital fund that provides technologies to the Central Intelligence Agency, from March 2001 to August 2002. Prior to joining In-Q-Tel, Mr. Richard served in various senior management positions at Matsushita Electric (Panasonic), a consumer electronics company. Mr. Richard is a former U.S. foreign service officer. He served in Osaka/Kobe, Japan and as a desk officer for North Korean, Greek and Turkish affairs at the U.S. Department of State in Washington, D.C. Mr. Richard previously served as chairman of the board of trustees of the International Biomedical Research Alliance, an academic joint venture among the NIH, Oxford University and Cambridge University. Mr. Richard received an M.A. in international relations from Johns Hopkins University School of Advanced International Studies and a B.A. in history from Washington University. He holds honorary doctorates in humane letters from Notre Dame College and Baldwin Wallace College.
As the Lead Independent Director of Emergent Biosolutions Inc, the total compensation of Ronald Richard at Emergent Biosolutions Inc is $390,500. There are 11 executives at Emergent Biosolutions Inc getting paid more, with Robert Kramer having the highest compensation of $3,693,820.
Ronald Richard is 64, he's been the Lead Independent Director of Emergent Biosolutions Inc since 2014. There are 6 older and 14 younger executives at Emergent Biosolutions Inc. The oldest executive at Emergent Biosolutions Inc is Louis Sullivan, 86, who is the Independent Director.
Ronald's mailing address filed with the SEC is 300 PROFESSIONAL DR, , GAITHERSBURG, MD, 20879.
Over the last 18 years, insiders at Emergent Biosolutions Inc have traded over $131,382,266 worth of Emergent Biosolutions Inc stock and bought 4,647 units worth $138,981 . The most active insiders traders include Seamus Mulligan, Fuad El Hibri y Shahzad Malik. On average, Emergent Biosolutions Inc executives and independent directors trade stock every 21 days with the average trade being worth of $147,206. The most recent stock trade was executed by Kathryn C Zoon on 4 June 2024, trading 10,000 units of EBS stock currently worth $61,100.
emergent biosolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. we develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. through our work, we envision protecting and enhancing 50 million lives with our products by 2025. additional information about the company may be found at www.emergentbiosolutions.com. follow us @emergentbiosolu and @life_at_emergent
Emergent Biosolutions Inc executives and other stock owners filed with the SEC include: